Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Tandem Diabetes Care — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plans Book a 15-min walkthrough

▶

Watch the 2-minute tour · with sound

Tandem Diabetes Care Partners with UVA for Advanced Insulin Delivery Systems

Jan 07, 2025•over 1 year ago

Contract Type

partnership

San DiegoManufacturingHealth Care

Description

Tandem Diabetes Care, Inc. announced a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA) to advance research and development efforts on fully automated closed-loop insulin delivery systems. The collaboration will rely on UVA's groundbreaking work to improve care for patients with diabetes through technology-based interventions and Tandem's expertise in insulin delivery devices, algorithm implementation, and data management.

Company Information

Company

Tandem Diabetes Care

Location

Roselle Street

San Diego, California, United States

About

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California.

Predictive Intelligence

Strategic

ML-powered predictions for Tandem Diabetes Care's next move

Learn about Strategic plan

Related People

Suggested for you

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months